Search Within

Neil Harrison Bander

Formats
  1. Journal Article (41)
  2. Meeting Abstract (17)
  3. Book Section (2)
  4. Book Whole (1)
  5. Conference Paper (1)
Groups
  1. Department of Medicine (18)
  2. Sloan Kettering Institute Faculty (18)
  3. Genitourinary Oncology Service (17)
  4. Solid Tumor Oncology Division (17)
  5. Molecular Imaging and Therapy Service (16)
  6. Molecular Pharmacology and Chemistry Program Faculty (16)

More Groups

People
  1. Lloyd Old (17)
  2. Steven Larson (14)
  3. Carlos Cordon-Cardo (11)
  4. Connie Finstad (11)
  5. Howard Scher (10)
  6. Michael Morris (9)

More People

Years
  1. 2016 (1)
  2. 2015 (3)
  3. 2014 (2)
  4. 2013 (2)
  5. 2012 (2)
  6. 2011 (2)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Journal of Urology (8)
  3. Journal of Nuclear Medicine (4)
  4. Proceedings of the National Academy of Sciences of the United States of America (4)
  5. Cancer Research (3)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. Elsevier Science, Inc. (10)
  2. American Association for Cancer Research (9)
  3. American Society of Clinical Oncology (8)
  4. National Academy of Sciences (4)
  5. Society of Nuclear Medicine (4)
  6. Elsevier Inc. (3)

More Publishers

Results (62)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
    Journal Article

    Milowsky, M. I.; Galsky, M. D.; Morris, M. J.; Crona, D. J.; George, D. J.; Dreicer, R.; Tse, K.; Petruck, J.; Webb, I. J.; Bander, N. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2016)

    Fulltext@MSK | Save
  • A phase I/II study for analytic validation of 89Zr-J591 immunoPET as a molecular imaging agent for metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Durack, J. C.; Lyashchenko, S. K.; Cheal, S. M.; Beylergil, V.; Lefkowitz, R. A.; Carrasquillo, J. A.; Martinez, D. F.; Fung, A. M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Martinez, D. F.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; Martinez, D. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of bone metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled anti-prostate specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; Beylergil, V.; O'Donoghue, J. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Noninvasive measurement of prostate-specific membrane antigen (PSMA) expression with radiolabeled J591 imaging: A prognostic tool for metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Tagawa, S. T.; Akhtar, N. H.; Christos, P. J.; Osborne, J.; Vallabhajosula, S.; Freedy, S.; Goldsmith, S. J.; Nanus, D. M.; Bander, N. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
    Journal Article

    Tagawa, S. T.; Milowsky, M. I.; Morris, M.; Vallabhajosula, S.; Christos, P.; Akhtar, N. H.; Osborne, J.; Goldsmith, S. J.; Larson, S.; Taskar, N. P.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Antibody-drug conjugate technology development for hematologic disorders
    Journal Article

    Bander, N. H.; Czuczman, M. S.; Younes, A.
    Clinical Advances in Hematology & Oncology (2012)

    Fulltext@MSK | Save
  • Overview of antibody-drug conjugate technology for the clinician
    Journal Article

    Bander, N. H.
    Clinical Advances in Hematology & Oncology (2012)

    Fulltext@MSK | Save